Infectious Complications Associated with the Use of Antithymocyte Globulin in Reduced Intensity Allogeneic Transplants

Kara Loth^1*, Seema Naik², Leanne Kennedy¹, Gregory Russell³, Denise Levitan², Kenneth Zamkoff² and David Hurd²

¹Department of Pharmacy, Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, USA

²Department of Bone Marrow Transplant, Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, USA

³Public Health Sciences, Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, USA

^*Corresponding Author: Kara Loth, PharmD, Department of Pharmacy, Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, USA, Tel: 336-716-6292, Fax: 336-716-1090 Email: